CS logo
small CS logo
North Texas Infectious Diseases Consultants

Dallas, Texas, United States
Infectious disease physician in Dallas, Texas
3409 Worth St, Dallas, TX 75246

About North Texas Infectious Diseases Consultants


"Our Dallas clinical research center is one of the most respected & sought-after locations in North Texas, specializing in infectious disease research."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
19
TaiMed Biologics Inc.
6
Pfizer
4
BioNTech SE
3
Hoffmann-La Roche
2
Janssen Scientific Affairs, LLC
2
Janssen Vaccines & Prevention B.V.
2
Avexa
1
Bristol-Myers Squibb
1
Janssen Research & Development, LLC
1
National Institute of Allergy and Infectious Diseases (NIAID)
1
Total Rows: 13

Clinical Trials at North Texas Infectious Diseases Consultants


During the past decade, North Texas Infectious Diseases Consultants conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 23 clinical trials were completed, i.e. on average, 76.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66113322443355660077223311443322Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
Completed
825
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Unknown status
500
Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
2008-02-01
2010-01-01
Terminated
239
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
2008-07-01
2015-04-01
Completed
724
Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
2008-08-01
2011-04-01
Completed
113
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
2011-09-01
2014-01-01
Terminated
813
Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
2011-02-01
2014-07-01
Terminated
297
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
2011-12-01
2017-07-07
Completed
26

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "North Texas Infectious Diseases Consultants" #1 sponsor was "Gilead Sciences" with 19 trials, followed by "TaiMed Biologics Inc." with 6 trials sponsored, "Pfizer" with 4 trials sponsored, "BioNTech SE" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "North Texas Infectious Diseases Consultants" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Westat" with 3 trials as a collaborator and "SIGA Technologies" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 19Gilead Sciences: 19TaiMed Biologics Inc.: 6TaiMed Biologics Inc.: 6Pfizer: 4Pfizer: 4BioNTech SE: 3BioNTech SE: 3Hoffmann-La Roche: 2Hoffmann-La Roche: 2Janssen Scientific Affairs, LLC: 2Janssen Scientific Affairs, LLC: 2Janssen Vaccines &Prevention B.V.: 2Janssen Vaccines &Prevention B.V.: 2Avexa: 1Avexa: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 3Pfizer: 3Westat: 3Westat: 3SIGA Technologies: 1SIGA Technologies: 1

Clinical Trials Conditions at North Texas Infectious Diseases Consultants


According to Clinical.Site data, the most researched conditions in "North Texas Infectious Diseases Consultants" are "HIV" (8 trials), "HIV Infections" (8 trials), "HIV-1 Infection" (8 trials), "HIV-1-infection" (8 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "North Texas Infectious Diseases Consultants" in a lesser frequency.

Clinical Trials Intervention Types at North Texas Infectious Diseases Consultants


Most popular intervention types in "North Texas Infectious Diseases Consultants" are "Drug" (33 trials), "Biological" (11 trials), "Other" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "B/F/TAF" (8 trials), "E/C/F/TAF" (7 trials), "B/F/TAF Placebo" (3 trials) and "BNT162b2" (3 trials). Other intervention names were less common.

Clinical Trials Genders at North Texas Infectious Diseases Consultants


The vast majority of trials in "North Texas Infectious Diseases Consultants" are 43 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at North Texas Infectious Diseases Consultants


Currently, there are NaN active trials in "North Texas Infectious Diseases Consultants". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in North Texas Infectious Diseases Consultants, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in North Texas Infectious Diseases Consultants, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 33Phase 3: 33Phase 2: 11Phase 2: 11Phase 1: 5Phase 1: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 25Completed: 25Active, not recruiting: 9Active, not recruiting: 9Recruiting: 6Recruiting: 6Terminated: 3Terminated: 3Unknown status: 1Unknown status: 1